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Saudi Journal of Ophthalmology (2012) 26, 205–210Original ArticleHistochemical analysis and immunohistochemical profile of
mucoepidermoid carcinoma of the conjunctivaAndré Jastrzebski, MD a,b; Seymour Brownstein, MD a,b,⇑; David R. Jordan, MD a; Steven M. Gilberg, MD aAbstractPurpose: To elucidate the distinct histochemical and immunohistochemical profile of mucoepidermoid carcinoma of the conjunc-
tiva (MECC) and to determine which combination of stains is most useful in diagnosing MECC and differentiating it from squamous
cell carcinoma of the conjunctiva (SCC) in cases where the clinical or cytological findings are not definitive.
Methods: Eight specimen of MECC from 4 patients and 4 specimens of SCC from 4 patients were examined using a variety of
special stains and immunohistochemical markers. The results were then analyzed for usefulness in diagnosing MECC.
Results: The most useful markers in diagnosing MECC and differentiating it from SCC are mucicarmine, colloidal iron, and alcian
blue all with sensitivities of 88%, and a specificity of 100%; CEA with a sensitivity of 83% and a specificity of 75%; and, mucin-1 with
a sensitivity of 100% and a specificity of 25%, but which showed a distinct pattern of staining of MECC when compared to SCC. In
our series, the sensitivity of the CK7+/CK20 combination for MECC was only 38%.
Conclusions: The most useful stains in ruling out SCC in a suspected case of MECC were shown to be mucicarmine and the
glycosaminoglycan (GAG) stains. However, in cases where mucicarmine and the GAG stains are negative or difficult to interpret
and there is suspicion of a diagnosis of MECC, CEA and mucin-1 may be helpful for this diagnosis. The findings of CK7+/CK20
also may be of assistance, but are not as sensitive when compared to analogous salivary gland lesions, when differentiating MECC
from SCC.
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Mucoepidermoid carcinoma is a malignant neoplasm con-
taining both squamous cells and mucus-producing cells. It
arises primarily in the salivary glands and the occurrence of
mucoepidermoid carcinoma of the conjunctiva (MECC) is ex-
tremely rare.1–6 A review of the literature revealed only 23 re-
ported cases.6,7 In addition to its rarity, MECC may be
difficult to diagnose and is often mistaken for the more com-
mon squamous cell carcinoma of the conjunctiva (SCC) which,Peer review under responsibility
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aggressive behavior.5,6
The rarity of MECC, along with the lack of investigations
into its identification, has led us to review the literature on
mucoepidermoid carcinoma of the major salivary glands,
which occurs much more frequently. In this report, we pres-
ent the histochemical analysis and immunohistochemical pro-
file of eight specimens from four cases of MECC diagnosed
by our ophthalmic pathology laboratory. We also outline
the most useful stains for aiding in the diagnosis of MECC
and for differentiating it from SCC.j Production and hosting by ElsevierAccess this article online: www.saudiophthaljournal.comwww.sciencedirect.com
uary 2012.
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Eight specimens of MECC from four patients and 4 speci-
mens of SCC from four patients were retrieved and processed
with a series of histochemical and immunohistochemical
stains. We were not able to test every specimen for every stain
due to the limited amount of tissue available for analysis. The
histochemical stains included period acid-Schiff (PAS) with
diastase, alcian blue, colloidal iron, and mucicarmine. The
immunohistochemical stains included BRST-1, BRST-2
(GCDFP-15), cytokeratins (CK) 7 and CK20, high and low
molecular weight keratin (HMWK & LMWK), carcinoembry-
onic antigen (CEA), epithelial membrane antigen (EMA), and
mucin-1. The staining patterns were then examined by 2 of
the authors (A.J., S.B.).Results
The four cases of MECC analyzed in this study have been
previously reported.5,6 Table 1 summarizes the clinical pre-
sentation, management, and follow up in the four cases of
MECC analyzed. Labeling of the patients in Table 1 corre-
sponds with the labeling of the clinical images in Fig. 1.
Two of the four patients diagnosed histologically with MECC
presented with the primary complaint of a conjunctival mass,
one presented with unilateral eye irritation and a recent his-
tory of an ocular surface foreign body, and one patient had
a long history of ocular irritation and a diagnosis of ocular cic-
atricial pemphigoid (OCP). Two of the lesions were tempo-
rally located, one of which extended into the cornea
(Fig. 1A and B); one was medial (Fig. 1C), and the lesion diag-
nosed as OCP was inferior (Fig. 1D). Histologically, three of
the lesions were diagnosed initially as MECC and the medial
conjunctival lesion was diagnosed initially as SCC. Initial sur-
gical excision was unsuccessful in all cases, with tumor cells
extending to the surgical margins. Recurrence of the lesion
occurred in all cases after initial excision. One patient with
a temporal lesion with limbal involvement required repeated
local excisions with eventual control of the lesion. Three spec-
imens were obtained from this patient. The other temporally
located lesion required multiple sessions of radiation therapy
and was eventually treated with enucleation of the affectedTable 1. Summary of presentation, management, and follow up for each patie
Patient Presentation Initial
manage
A. 3 Specimens
analyzed
Temporal conjunctival mass Excisona
B. 3 Specimens
analyzed
Temporal conjunctival mass extending into
the cornea
Excisona
C. 1 Specimen
analyzed
Unilateral ocular irritation and recent foreign
body
Excisona
D. 1 Specimen
analyzed
Inferior mass with ocular surface irritation
and history of OCP
Biopsy o
suspecte
* MECC, mucoepidermoid carcinoma of the conjunctiva.
 SCC, squamous cell carcinoma of the conjunctiva.
 OCP, ocular cicatricial pemphigoid.eye with clear margins. Three specimens were obtained from
this patient. The patient with an inferior conjunctival lesion in
an eye with OCP was treated by orbital exenteration but
eventually developed lymph node and liver metastases.
One specimen was obtained from this patient. The patient
with a medial conjunctival lesion developed regional lymph
node metastases requiring radical neck dissection and radia-
tion treatment. One specimen was obtained from this
patient.
Fig. 2A shows the typical biphasic histology of MECC and
Fig. 2B highlights the mucinous nature of the lesion using the
alcian blue stain. The results of the histochemical and immu-
nohistochemical profiles of all specimens of MECC for the se-
lected stains are summarized in Tables 2 and 3. There was
staining of the conjunctival MECC specimens with alcian blue
in 88% specimens, colloidal iron in 88%, mucicarmine in 88%,
PAS with diastase in 71%, BRST-1 in 38%, CEA in 83%, CK-7
in 38%, EMA in 75%, HMWK in 63%, LMWK in 38%, and mu-
cin-1 in 100%. Only BRST-2 and CK-20 stained none of the
conjunctival MECC specimens.
The staining pattern of the cases of SCC is summarized in
Tables 4 and 5. Positive staining of the conjunctival SCC
specimens was seen for PAS with diastase in 25% of cases,
BRST-1 in 25%, CEA in 25%, EMA in 67%, HMWK in 100%,
and mucin-1 in 75%. None of the conjunctival SCC specimens
stained positive for alcian blue, colloidal iron, mucicarmine,
BRST-2, CK-7, CK-20, or LMWK.
The most informative of these results proved to be those
for mucicarmine, alcian blue, colloidal iron, CEA, and mu-
cin-1. The sensitivities and specificities of these markers are
summarized in Table 6. As was expected, mucicarmine, alcian
blue, and colloidal iron had an identical staining pattern, each
staining 7 of 8 specimens tested and each negative for the
same specimen. As is often the convention in previous re-
ports of MECC and mucoepidermoid carcinoma elsewhere
in the body, we chose mucicarmine as our preferred method
for showing mucinous production in the specimens because
of its specificity for mucin and its relative ease for screening
because of the high contrast between the mucin and the
background staining (Fig. 2C).8,9 Mucicarmine showed a sen-
sitivity of 88% and a specificity of 100% in differentiating
MECC from SCC; CEA (Fig. 2D), a sensitivity of 83% and a
specificity of 75%; and mucin-1, a sensitivity of 100% and ant with MECC.
ment
Initial
pathology
Follow up
l biopsy MECC* Repeated local excisions
Positive
margins
l biopsy MECC* Repeated local excisions, radiation,
enucleationPositive
margins
l biopsy SCC Nodal metastases treated with radiation
and neck dissectionPositive
margins
f
d OCP
MECC* Exenteration Eventual nodal and hepatic
metastasesPositive
margins
Figure 1. (A) The right eye shows MECC presenting as an elevated temporal bulbar and adjacent limbal conjunctival mass. (B) The right eye shows
MECC presenting as a lateral limbal conjunctival lesion invading the temporal cornea (M). (C) The right eye shows MECC presenting as a medial bulbar,
plical, and inferomedial forniceal conjunctival mass. (D) The left eye shows MECC filling and obliterating most of the inferior fornix.
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mucin stains; with the same specimen which was mucin neg-
ative also being CEA negative. It was also noted that
although mucin-1 stained the majority of specimens for both
MECC and SCC, there was a noticeable difference in the stain-
ing pattern between the two types of carcinomatous lesions.
Fig. 2E shows the diffuse, intense, cytoplasmic staining of
MECC compared to the less intense staining of the SCC spec-
imens in Fig. 2F, which tended to involve predominantly the
cell membranes and intercellular bridges. Of note, the combi-
nation of CK7+/CK20 showed a sensitivity of only 38%, but a
specificity of 100% for differentiating MECC from SCC.Discussion
Mucoepidermoid carcinoma is the most common malignant
tumor of the major salivary glands; however, MECC is extre-
mely rare with only 23 cases having been reported in the liter-
ature.5,6,10 Ocular mucoepidermoid carcinoma has also been
reported to occur in the eyelids, the lacrimal gland, and the lac-
rimal sac.11 MECC provides both a clinical and histopatholo-
gical challenge as it is frequently very difficult to differentiate
from the much more common, SCC. This differentiation how-
ever, is very important because of the much more aggressive
clinical course of MECC.5,6 Previous case series have reported
an average age of diagnosis of between 52 and 67 years of age
and have shown that the recurrence rate is extremely common
ranging from 84% to 100% in different reports consistent with
the highly aggressive nature of this malignancy.3,5,6MECC has a variable histological pattern with different
degrees of epidermoid and mucinous differentiation. The
epidermoid cells have abundant cytoplasm and atypical nuclei
within polygonal cells, whereas the mucinous components
consist of columnar and cuboidal cells with intracytoplasmic
mucin.11 It has been postulated that mucinous differentiation
in MECC exists only as a consequence of intraocular invasion
and that the differentiation is in fact secondary to intraocular
factors.3,6 However, pure squamous differentiation has been
seen in the intraocular recurrence of a case of MECC, and
mucinous components have been identified in purely extraoc-
ular cases.6
In our study we have shown the distinct histochemical and
immunohistochemical staining profile of MECC which has not
been reported previously. We also have provided a combina-
tion of stains which can be used to identify a suspected case
of MECC. The combination of mucicarmine, colloidal iron, al-
cian blue, mucin-1, and CEA was shown in our cases to pro-
vide a highly sensitive and specific group of stains which
can be used to help with the diagnosis of this very rare entity.
Though an identical staining pattern to mucicarmine was ob-
served for colloidal iron and alcian blue, and though these
stains will most likely be ordered along with mucicarmine,
we have selected mucicarmine as the single best stain to
definitively diagnose MECC, with its 100% specificity, higher
contrast staining, and its well established utility in the diagno-
sis of MECC and mucoepidermoid carcinoma elsewhere in
the body.8,9 Because mucicarmine is less than 100% sensitive,
mucin-1 and CEA are useful adjuncts in suspected cases
where mucicarmine is negative or difficult to interpret.
Figure 2. (A) MECC with epidermoid features demonstrated by keratinization (K) and mucinous features (arrows) (hematoxylin-eosin, 200). (B) The
alcian blue stain highlights the mucinous nature of MECC (alcian blue, 200). (C) Focal intracellular and intercellular staining of MECC for mucin
(mucicarmine 1600). (D) Abundant focal staining for CEA in a MECC (CEA immunoperoxidase, 640). (E) Immunohistochemical staining pattern of
MECC for mucin-1. The staining is diffuse and cytoplasmic (mucin-1 immunoperoxidase, 1600). (F) Typical immunohistochemical staining pattern of
SCC for mucin-1. The staining is predominantly limited to the plasma membrane and intercellular bridges (mucin-1 immunoperoxidase, 1600).
Table 2. Histochemical staining pattern of
selected markers for MECC.
Markers Positive reactions
Alcian blue 7/8 (88%)
Colloidal iron 7/8 (88%)
Mucicarmine 7/8 (88%)
PAS*w/diastase 5/7 (71%)
* PAS, period acid-Schiff.
Table 3. Immunohistochemical staining pattern of selected markers for
MECC.
Markers Positive reactions Grading of reactivity
0 +1 +2 +3 +4
BRST-1 3/8 (38%) 5 1 1 1 0
BRST-2 0/8 (0%) 8 0 0 0 0
CEA* 5/6(83%) 1 0 0 4 1
CK 7 3/8 (38%) 5 0 1 0 2
CK 20 0/8 (0%) 8 0 0 0 0
EMA 6/8(75%) 2 0 3 0 3
HMWK§ 5/8 (63%) 3 0 1 2 2
LMWK|| 3/8(38%) 5 0 1 2 0
Mucin-1 8/8 (100%) 0 0 0 0 8
* CEA, carcinoembryonic antigen.
 CK, cytokeratin.
 EMA, epithelial membrane antigen.
§ HMWK, high molecular weight keratin.
|| LMWK, low molecular weight keratin.
208 A. Jastrzebski et al.However, in all of our cases, the specimens negative for muci-
carmine were also negative for CEA. Also, the low specificity
of mucin-1 may be negated in part by the noticeable differ-
ence in the staining pattern between cases of MECC and
SCC despite both staining positively. Though mucin-1 is a
more sensitive marker, CEA also was shown to be a highly
Table 4. Histochemical staining pattern of
selected markers for SCC.
Markers Positive reactions
Alcian blue 0/4 (0%)
Colloidal iron 0/4 (0%)
Mucicarmine 0/4 (0%)
PAS* with diastase 1/4 (25%)
* PAS, period acid-Schiff.
Table 5. Immunohistochemical staining pattern of selected markers for
SCC.
Markers Positive reactions Grading of reactivity
0 +1 +2 +3 +4
BRST-1 1/4 (25%) 3 0 1 0 0
BRST-2 0/4 (0%) 4 0 0 0 0
CEA* 1/4 (25%) 3 1 0 0 0
CK 7 0/4 (0%) 4 0 0 0 0
CK 20 0/4 (0%) 4 0 0 0 0
EMA 2/3 (67%) 1 1 1 0 0
HMWK§ 3/3 (100%) 0 1 2 0 0
LMWK|| 0/3 (0%) 3 0 0 0 0
Mucin-1 3/4 (75%) 1 1 0 2 0
* CEA, carcinoembryonic antigen.
 CK, cytokeratin.
 EMA, epithelial membrane antigen.
§ HMWK, high molecular weight keratin.
|| LMWK, low molecular weight keratin.
Table 6. Selected positive markers of MECC.
Marker Sensitivity (%) Specificity (%)
Mucicarmine 88 100
Alcian blue 88 100
Colloidal iron 88 100
Mucin-1 100 25
CEA* 83 75
CK7+/CK20 38 100
* CEA, carcinoembryonic antigen.
 CK, cytokeratin.
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sitivity and specificity for diagnosing MECC.
Though not previously described in the ophthalmic litera-
ture, the usefulness of CEA in the diagnosis of mucoepider-
moid carcinomas has been shown previously in cases
involving the major salivary glands.10 In 2004, Perez and col-
leagues10 reported on the immunohistochemical profile of
salivary gland tumors and found that 87.5% of mucoepider-
moid carcinoma stained positive for CEA. It also has been re-
ported that the serum CEA level may be increased in patients
with bronchial mucoepidermoid carcinoma, and shows even-
tual return to normal levels after tumor removal.10,12
Both benign and malignant salivary gland neoplasms,
including mucoepidermoid carcinoma, are characteristically
CK7+/20.13 This is worth noting, as much of our knowledge
on MECC is derived from its salivary gland counterpart. In
contrast to the available data on salivary gland malignancies,
our data did not show a similar staining pattern for CK7 and
CK20. Though no cases stained positive for CK20, only 38%
of our MECC cases stained positive for CK7. The combinationof CK7+/CK20 is a less sensitive marker, and MECC has a
pattern close to that seen in SCC, which is characteristically
CK7/20.13 This limits the usefulness of these stains in the
diagnosis of MECC, although a positive CK7 finding could
be of diagnostic assistance.
The accurate diagnosis of MECC provides valuable clinical
information to help guide further management; however, no
well defined treatment plan exists for the management of this
rare condition. At a minimum, wide local excision is strongly
recommended. Some authors have suggested the addition
of local adjuvant cryotherapy, or plaque radiotherapy.5,6 Oth-
ers have recommended more aggressive management,
including enucleation of the affected eye and/or exenteration
of the orbital contents which often are required in cases of
extensive tumor, especially with intraocular and/or orbital
invasion.5,6 No matter the plan of management, recurrence,
especially after the initial excision, is extremely common.5,6
Fortunately, though MECC is extremely locally aggressive,
metastases to distant sites are rare with confirmed regional
lymph node metastases identified in only 4 cases (with 2
cases included in this study).5,6
In conclusion, we present the previously unreported histo-
chemical and immunohistochemical profile of MECC. We
have shown the usefulness of several tests in the diagnosis
of MECC and its differentiation from the much more common
SCC. In particular, we have shown mucicarmine to be a very
specific stain for the diagnosis of MECC, which can be com-
bined with mucin-1 and CEA to improve the yield of the diag-
nosis of MECC, possibly when mucicarmine is negative or
difficult to interpret. CEA has previously been shown to be
a useful marker in identifying mucoepidermoid carcinoma
of the major salivary glands, with similar results to those ob-
tained in our study. We have also shown that MECC does not
possess a similar pattern of CK7+/CK20 staining to that
seen with mucoepidermoid carcinoma of the salivary glands.
With most of our cases, MECC staining is similar to SCC lim-
iting the diagnostic utility of these tests; however, when po-
sitive, CK7 may add to the diagnostic armamentarium for
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